Acid sphingomyelinase
Acid sphingomyelinase (aSMase, encoded by SMPD1) is a lysosomal and secreted enzyme that hydrolyses sphingomyelin – a phospholipid abundant in keratinocyte membranes – to produce ceramide and phosphocholine. In skin barrier biology, it operates as one of two extracellular processing enzymes that convert lamellar body-secreted ceramide precursors into the free ceramides the stratum corneum’s lamellar matrix requires. Its partner enzyme, β-glucocerebrosidase, handles the glucosylceramide conversion; aSMase handles the sphingomyelin-to-ceramide route. [2]
pH Dependency and the Acid Mantle Relationship
aSMase has a pH optimum of approximately 4.5 – the most acidic of the ceramide-processing enzymes. This places it at the steeper end of the acid mantle’s dependency range: activity falls substantially as pH rises above 5.5 and approaches negligible at neutral pH. In the middle zone of the stratum corneum, where acid mantle pH is maintained at 4.7–5.5, aSMase operates close to its optimal range. When this zone is disrupted – by alkaline cleansers, hard water, ageing-related NHE1 decline, or inflammatory conditions – aSMase is the ceramide-processing enzyme most immediately impaired, given its steep pH sensitivity. [1]
Impairment in Atopic Dermatitis
aSMase activity is measurably reduced in atopic dermatitis skin independently of pH – a finding confirmed in stratum corneum tape strip analysis comparing atopic and non-atopic subjects. This means that in atopic presentations, aSMase activity is compromised through two concurrent mechanisms: the alkaline pH shift characteristic of atopic SC, and reduced enzyme expression or activity in the tissue itself. The result is a sphingomyelin-to-ceramide conversion bottleneck that persists even when surface acidification is partially corrected, which partially explains why barrier repair in atopic skin is slower and less complete than the same interventions produce in non-atopic barrier disruption. [2]
The UV Stress Signalling Role
Beyond the barrier processing function, aSMase has a distinct role in stress-response signalling. UV radiation activates aSMase in keratinocytes through a ceramide-mediated apoptosis pathway – the ceramide generated is not destined for the barrier matrix but acts as a lipid second messenger initiating apoptotic signalling in UV-damaged cells. This is a separate pool and a separate function; the two roles share the enzyme but operate in different cellular compartments under different conditions. [3]
For the full clinical context of ceramide processing enzyme pH dependency, see the Acid Mantle entity. For the broader ceramide synthesis picture, see Ceramides and Serine palmitoyltransferase.
References
Choi EH, Kang H (2024). Importance of Stratum Corneum Acidification to Restore Skin Barrier Function in Eczematous Diseases. Ann Dermatol, 36(1), 1-8 . doi.org/10.5021/ad.23.078
Jensen JM, Fölster-Holst R, Baranowsky A, et al. (2004). Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol, 122(6), 1423-31 . doi.org/10.1111/j.0022-202x.2004.22621.x
Uchida Y, Nardo AD, Collins V, et al. (2003). De novo ceramide synthesis participates in the ultraviolet B irradiation-induced apoptosis in undifferentiated cultured human keratinocytes. J Invest Dermatol, 120(4), 662-9 . doi.org/10.1046/j.1523-1747.2003.12098.x
Also Known As
- acid sphingomyelin phosphodiesterase
- ASM
- aSMase
- SMPD1
- sphingomyelin phosphodiesterase 1
Learn More
This topic is discussed in 1 article:
-

The enzyme that converts sphingomyelin to ceramide via the sphingomyelinase pathway. Active in both lamellar body secretion and UV-induced keratinocyte stress signalling.